Used in pharmaceutical research as a potent inhibitor of soluble epoxide hydrolase (sEH), this compound shows promise in the development of treatments for inflammatory diseases, neuropathic pain, and cardiovascular conditions. Its structure allows for high selectivity and improved metabolic stability, making it a valuable scaffold in optimizing drug candidates targeting chronic inflammation and related disorders. Studies also explore its potential in modulating pain pathways without central nervous system side effects, supporting its use in next-generation analgesics.